Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Conjupro Biotherapeutics, Inc.
Protara Therapeutics
Atavistik Bio, Inc
Relmada Therapeutics, Inc.
Insel Gruppe AG, University Hospital Bern
Centre Hospitalier Universitaire, Amiens
K36 Therapeutics, Inc.
Centre Oscar Lambret
Centre Oscar Lambret
VA Office of Research and Development
Yonsei University
University of California, San Diego
Chinese University of Hong Kong
Boston Scientific Corporation
UroTrials Company (GmbH)
The Methodist Hospital Research Institute
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Relmada Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Amgen
UMC Utrecht
University of Oklahoma
University College Cork
Peter MacCallum Cancer Centre, Australia
Nuvectis Pharma, Inc.
Psyence Australia Pty Ltd
ViroMissile, Inc.
Tianjin Medical University Second Hospital
Assistance Publique - Hôpitaux de Paris
Rutgers, The State University of New Jersey
Pfizer
Duke University
Wake Forest University Health Sciences
Cedars-Sinai Medical Center
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Janssen Research & Development, LLC